According to Fortune Business Insights, the global Continuous Renal Replacement Therapy (CRRT) market was valued at USD 1.16 billion in 2024. It is expected to grow from USD 1.25 billion in 2025 to USD 2.14 billion by 2032, registering a CAGR of 8.0% during the forecast period. In 2024, North America dominated the CRRT market with a share of 39.66%.
